199
Views
41
CrossRef citations to date
0
Altmetric
Original Article

Tumor Reoxygenation as a Mechanism of Taxol-Induced Enhancement of Tumor Radioresponse

, , , &
Pages 409-412 | Received 10 Oct 1994, Accepted 21 Dec 1994, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

I. Skvortsova, S. Skvortsov, A. Haidenberger, A. Devries, M. Nevinny-Stickel, M. Saurer, P. Lukas & T. Seppi. (2004) Effects of Paclitaxel and Docetaxel on EGFR-Expressing Human Carcinoma Cells Under Normoxic Versus Hypoxic Conditions In Vitro . Journal of Chemotherapy 16:4, pages 372-380.
Read now
Maria Constantinou, James Y. Tsai & Howard Safran. (2003) Paclitaxel and Concurrent Radiation in Upper Gastrointestinal Cancers. Cancer Investigation 21:6, pages 887-896.
Read now

Articles from other publishers (39)

Bernard Gallez. (2022) The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia. Frontiers in Pharmacology 13.
Crossref
G.C. van Rhoon, M. Franckena & T.L.M. ten Hagen. (2020) A moderate thermal dose is sufficient for effective free and TSL based thermochemotherapy. Advanced Drug Delivery Reviews 163-164, pages 145-156.
Crossref
John D. Martin & Rakesh K. Jain. 2020. Molecular Targeted Radiosensitizers. Molecular Targeted Radiosensitizers 301 338 .
Olli Metsälä, Joose Kreutzer, Heidi Högel, Petra Miikkulainen, Pasi Kallio & Panu M. Jaakkola. (2018) Transportable system enabling multiple irradiation studies under simultaneous hypoxia in vitro. Radiation Oncology 13:1.
Crossref
Yun Chen, Zhengfei Zhu, Weixin Zhao, Ling Li, Jinjun Ye, Chaoyang Wu, Huarong Tang, Qin Lin, Jiancheng Li, Yi Xia, Yunhai Li, Jialiang Zhou & Kuaile Zhao. (2018) A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol. Radiation Oncology 13:1.
Crossref
Lei Cui, Sohyoung Her, Gerben R. Borst, Robert G. Bristow, David A. Jaffray & Christine Allen. (2017) Radiosensitization by gold nanoparticles: Will they ever make it to the clinic?. Radiotherapy and Oncology 124:3, pages 344-356.
Crossref
Bernard Gallez, Marie-Aline Neveu, Pierre Danhier & Bénédicte F. Jordan. (2017) Manipulation of tumor oxygenation and radiosensitivity through modification of cell respiration. A critical review of approaches and imaging biomarkers for therapeutic guidance. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1858:8, pages 700-711.
Crossref
Hongmei Lin, Yuhchyau Chen, Anhui Shi, Kishan J. Pandya, Rong Yu, Yannan Yuan, Jiancheng Li, Hang Li, Yingjie Wang, Tingyi Xia, Linchun Feng, Huimin Ma, Jianhao Geng & Guangying Zhu. (2016) Phase 3 Randomized Low-Dose Paclitaxel Chemoradiotherapy Study for Locally Advanced Non-Small Cell Lung Cancer. Frontiers in Oncology 6.
Crossref
Thomas B. Brunner. (2016) The rationale of combined radiotherapy and chemotherapy – Joint action of Castor and Pollux. Best Practice & Research Clinical Gastroenterology 30:4, pages 515-528.
Crossref
G. Klautke & K. Müller. (2016) Chemotherapeutic agents for GI tumor chemoradiotherapy overview of chemotherapeutic agents to be combined with radiotherapy in the GI tract and their potential as radiosensitizers. Best Practice & Research Clinical Gastroenterology 30:4, pages 529-535.
Crossref
Christopher Douglas Willey, Eddy Shih-Hsin Yang & James A. Bonner. 2016. Clinical Radiation Oncology. Clinical Radiation Oncology 63 79.e4 .
Yongkun Wang, Chuanying Wang, Yijun Jia, Xianhua Cheng, Qing Lin, Mingjie Zhu, Yunshu Lu, Longlong Ding, Ziyi Weng & Kejin Wu. (2014) Oxygen-Carbon Nanotubes as a Chemotherapy Sensitizer for Paclitaxel in Breast Cancer Treatment. PLoS ONE 9:8, pages e104209.
Crossref
SHOJI KAKU, NORICHIKA USHIODA, HIROSHI ISHII, TAKASHI MURAKAMI, KENTARO TAKAHASHI, YUICHIRO NAKAI, KOICHIRO SHIMOYA & TAKAFUMI NAKAMURA. (2014) Timing of cisplatin administration for chemoradiotherapy in transgenic mice bearing lens tumors. Oncology Reports 32:1, pages 16-22.
Crossref
Encouse B. Golden, Silvia C. Formenti & Peter B. Schiff. (2014) Taxanes as radiosensitizers. Anti-Cancer Drugs 25:5, pages 502-511.
Crossref
Pierre Danhier, Christophe J. De Saedeleer, Oussama Karroum, Géraldine De Preter, Paolo E. Porporato, Bénédicte F. Jordan, Bernard Gallez & Pierre Sonveaux. (2013) Optimization of Tumor Radiotherapy With Modulators of Cell Metabolism: Toward Clinical Applications. Seminars in Radiation Oncology 23:4, pages 262-272.
Crossref
Bilge Gursel & Ayfer Haydaroglu. 2013. Principles and Practice of Modern Radiotherapy Techniques in Breast Cancer. Principles and Practice of Modern Radiotherapy Techniques in Breast Cancer 59 70 .
Mo-Fa Gu, Li-Zhi Liu, Long-Jun He, Wen-Xin Yuan, Rong Zhang, Guang-Yu Luo, Guo-Liang Xu, Hua-Man Zhang, Chao-Xian Yan & Jian-Jun Li. (2013) Sequential chemoradiotherapy with gemcitabine and cisplatin for locoregionally advanced nasopharyngeal carcinoma. International Journal of Cancer 132:1, pages 215-223.
Crossref
Christopher D. Willey & James A. Bonner. 2012. Clinical Radiation Oncology. Clinical Radiation Oncology 65 82 .
Shannon Fogh, Mitchell Machtay, Maria Werner-Wasik, Walter J. CurranJr.Jr., Roseann Bonanni, Rita Axelrod, David Andrews & Adam P. Dicker. (2010) Phase I Trial Using Patupilone (Epothilone B) and Concurrent Radiotherapy for Central Nervous System Malignancies. International Journal of Radiation Oncology*Biology*Physics 77:4, pages 1009-1016.
Crossref
Mark W. Dewhirst, Yiting Cao & Benjamin Moeller. (2008) Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nature Reviews Cancer 8:6, pages 425-437.
Crossref
Mark W. Dewhirst, Yiting Cao & Gordana Vlahovic. 2008. Antiangiogenic Agents in Cancer Therapy. Antiangiogenic Agents in Cancer Therapy 27 47 .
Yuji Toiyama, Yasuhiro Inoue, Junichiro Hiro, Eiki Ojima, Hideki Watanabe, Youhei Narita, Atuko Hosono, Chikao Miki & Masato Kusunoki. (2006) The range of optimal concentration and mechanisms of paclitaxel in radio-enhancement in gastrointestinal cancer cell lines. Cancer Chemotherapy and Pharmacology 59:6, pages 733-742.
Crossref
Tanguy Y Seiwert, Joseph K Salama & Everett E Vokes. (2007) The concurrent chemoradiation paradigm—general principles. Nature Clinical Practice Oncology 4:2, pages 86-100.
Crossref
Mark W. Dewhirst, Yiting Cao, Benjamin Moeller & Chuan-Yuan Li. 2006. Cancer Drug Resistance. Cancer Drug Resistance 3 19 .
Alphonse G. Taghian, Sherif I. Assaad, Andrzej Niemierko, Scott R. Floyd & Simon N. Powell. (2005) Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer?. International Journal of Radiation Oncology*Biology*Physics 62:2, pages 386-391.
Crossref
Yuhchyau Chen. 2005. Advances in Radiation Oncology in Lung Cancer. Advances in Radiation Oncology in Lung Cancer 481 493 .
Ellen L. Jones, Leonard R. Prosnitz, Mark W. Dewhirst, P. Kelly Marcom, Patricia H. Hardenbergh, Lawrence B. Marks, David M. Brizel & Zeljko Vujaskovic. (2004) Thermochemoradiotherapy Improves Oxygenation in Locally Advanced Breast Cancer. Clinical Cancer Research 10:13, pages 4287-4293.
Crossref
Marjeta Šentjurc, Maja Čemažar & Gregor Serša. (2004) EPR oximetry of tumors in vivo in cancer therapy. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 60:6, pages 1379-1385.
Crossref
Tyvin Rich, Jonathan Harris, R. Abrams, B. Erickson, M. Doherty, J. Paradelo, W. Small, H. Safran & Harold J. Wanebo. (2004) Phase II Study of External Irradiation and Weekly Paclitaxel for Nonmetastatic, Unresectable Pancreatic Cancer: RTOG-98-12. American Journal of Clinical Oncology 27:1, pages 51-56.
Crossref
Yuhchyau Chen & Paul Okunieff. (2004) Radiation and third-generation chemotherapy. Hematology/Oncology Clinics of North America 18:1, pages 55-80.
Crossref
Se Hoon ParkMi Kyung KimSun Young KyungYoung-Hee LimChang Hyeok AnJeong Woong ParkSeong Hwan JeongJae Woong LeeKyu Chan LeeEun Kyung ChoSoo Mee BangDong Bok ShinJae Hoon Lee. (2004) A Phase II Study of Weekly Paclitaxel, Cisplatin and Concurrent Radiation Therapy for Locally-Advanced Unresectable Non-Small Cell Lung Cancer: Early Closure due to Lack of Efficacy. Cancer Research and Treatment 36:5, pages 293.
Crossref
Yuhchyau Chen, Kishan Pandya, Peter P. Keng, Richard Feins, Richard Raubertas, Therese Smudzin, Joseph Rosenblatt & Paul Okunieff. (2001) Schedule-Dependent Pulsed Paclitaxel Radiosensitization for Thoracic Malignancy. American Journal of Clinical Oncology 24:5, pages 432-437.
Crossref
David I. RosenthalJason H. LeeRobert SinardDenise A. YardleyMitchell MachtayD. Marc RosenMerrill J. EgorinRandal S. WeberGregory S. WeinsteinAra A. ChalianLinda K. MillerEugene P. FrenkelDavid P. Carbone. (2001) Phase I Study of Paclitaxel Given by Seven-Week Continuous Infusion Concurrent With Radiation Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Journal of Clinical Oncology 19:5, pages 1363-1373.
Crossref
B. Brockstein, D.J. Haraf, K. Stenson, L. Sulzen, M.E. Witt, R.W. Weichselbaum & E.E. Vokes. (2000) A phase I–II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer. Annals of Oncology 11:6, pages 721-728.
Crossref
O. Pradier, D. Laurent, H. Schmidberger, M. Rave-Frank, K. Rubisch, M. Krebeck, E. Weiss & C.F. Hess. (1999) Étude in vitro de l'association paclitaxel-radiothérapie sur une lignée cellulaire tumorale épidermoïde humaine. Cancer/Radiothérapie 3:1, pages 51-56.
Crossref
M. Rave-Fränk, H. Meden, A. Jäschke, A. Tänzer, O. Boghun & R. Fietkau. (1997) The effect of paclitaxel on the radiosensitivity of gynecological tumor cellsDer Einfluß von Paclitaxel auf die Strahlensensitivität von Zellen gynäkologischer Tumoren. Strahlentherapie und Onkologie 173:5, pages 281-286.
Crossref
Julia A. O’Hara, Fuminori Goda, Jeffrey F. Dunn & Harold M. Swartz. 1997. Oxygen Transport to Tissue XVIII. Oxygen Transport to Tissue XVIII 233 242 .
Luka Milas, Yoshihiro Saito, Nancy Hunter, Christopher G. Milross & Kathryn A. Mason. (1996) Therapeutic potential of paclitaxel-radiation treatment of a murine ovarian carcinoma. Radiotherapy and Oncology 40:2, pages 163-170.
Crossref
Christopher G. Milross, Lester J. Peters, Nancy R. Hunter, Kathy A. Mason & Luka Milas. (2006) Sequence‐dependent antitumor activity of paclitaxel (taxol) and cisplatin in vivo. International Journal of Cancer 62:5, pages 599-604.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.